Consistent with this hypothesis, Tamburini et al. 83 noted that mTORC1 inhibition by RAD001 increased AKT activation in primary AML cells as a consequence of IRS2 upregulation via autocrine activation of IGF1/IGF1R signaling. The gene discussed is IGF1R; the disease is acute myeloid leukemia.